Home | About us | Editorial Board | Search | Ahead of print | Current Issue | Archives | Instructions | Online submissionContact Us   |  Subscribe   |  Advertise   |  Login  Page layout
Wide layoutNarrow layoutFull screen layout
Lung India Official publication of Indian Chest Society  
  Users Online: 808   Home Print this page  Email this page Small font size Default font size Increase font size
Year : 1991  |  Volume : 9  |  Issue : 3  |  Page : 95-98

Rifampicin-Metoclopramide Interaction - A Clinico Pharmacological Study

Correspondence Address:
S. D Purohit

Login to access the Email id

Source of Support: None, Conflict of Interest: None

Rights and PermissionsRights and Permissions

Untreated patients of pulmonary tuberculosis were given a rifampicin containing drug regimen along with placebo (Group I) or metoclopramide (Group II). Gastric emptying time, gastric pH, serum level of rifampicin and urinary excretion of rifampicin were estimated at different time intervals in all the patients. Adverse reactions, if any, were recorded. Metoclopramide led to a significant decline in gastric emptying time and rise in gastric pH. Mean peak serum levels of rifampicin were achieved earlier (90 minutes v/s 120 minutes) and were higher (9.82 ± 1.8 mg/ml v/s 8.14 ± 2.5 mg/ml) in presence of metoclopramide as compared to placebo. Metoclopramide did not change the frequency of rifampicin induced hepatitis but epigastric pain was significantly less.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded109    
    Comments [Add]    

Recommend this journal